tirzepatide surmount-1 nejm 2022 weight loss percent π Semaglutide 2.4mg: β13.7% (SURMOUNT-5 head-to-head), π 15mg: β20.2% weight loss (same trial, 2025), π Retatrutide 12mg: β28.7% weight loss (TRIUMPH-4, Phase 3, Dec SURMOUNT-1 Trial - Cardionerds Twitter
Pay in 4 interest-free payments of $7.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23



























